Zivo Bioscience, Inc.
ZIVO
$14.85
-$0.15-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.65% | 4.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -59.93% | 149.57% | |||
| Operating Income | 61.20% | -163.64% | |||
| Income Before Tax | 61.05% | -162.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 61.05% | -162.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 61.05% | -162.97% | |||
| EBIT | 61.20% | -163.64% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 61.67% | -148.56% | |||
| Normalized Basic EPS | 61.66% | -148.55% | |||
| EPS Diluted | 61.67% | -148.56% | |||
| Normalized Diluted EPS | 61.66% | -148.55% | |||
| Average Basic Shares Outstanding | 1.60% | 5.81% | |||
| Average Diluted Shares Outstanding | 1.60% | 5.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||